MedPath

Feasibility of Teleyoga for Treatment of Lyme Disease

Not Applicable
Completed
Conditions
Lyme Disease
Interventions
Behavioral: Teleyoga
Registration Number
NCT04867473
Lead Sponsor
Stanford University
Brief Summary

Primary Aims: Modify an existing teleyoga intervention to use with Lyme disease (LD) patients and address the technical challenges of at-home teleyoga

Detailed Description

Participants with symptoms of Lyme disease (n=15) will participate individually in a weekly tele-yoga class using an iPad loaned by the study. Participants will choose where to attend these remote treatment sessions. Yoga treatment will last 12 weeks. Participants' subjective pain will be rated at baseline and end-of-treatment using a standard pain scale. Also assessed will be participant adherence to study protocol by tracking treatment attendance

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Diagnosis of probable Lyme disease
  • Has not begun new pain medications or other treatments in the last month
  • English literacy
  • Wireless internet connection at home
Read More
Exclusion Criteria
  • Participation in another concurrent clinical trial
  • Back surgery within the last 12 months
  • Unstable, coexisting mental illness or psychiatric condition
  • Active, current suicidal intent or plan
  • Attended or practiced yoga ≥ 1 x in the past 12 months
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TeleyogaTeleyogaLyme disease participants will attend home-based yoga sessions using HIPAA-compliant telehealth software and devices and complete pain inventory questionnaires pre and post-treatment
Primary Outcome Measures
NameTimeMethod
Change of Pain Score From BaselineMeasured at baseline and again at the end of 12 weeks of treatment

Scores on the Pain, Enjoyment, General Activity (PEG) Scale; with values from 0 to 10 and higher scores indicating worse outcomes

Secondary Outcome Measures
NameTimeMethod
Adherence to the Treatment Protocolat study completion, an average of 7 months

Percentage of participants who attend ≥65 percent of treatment sessions; values range from 0 percent to 100 percent with higher percentages indicative of a better outcome

Trial Locations

Locations (1)

Stanford University

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath